UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
SCHEDULE 13G
|
||
Under the Securities Exchange Act of 1934
|
||
(Amendment No. )*
|
EyeGate Pharmaceuticals, Inc.
|
||
(Name of Issuer)
|
Common Stock, $0.01 par value per share
|
||
(Title of Class of Securities)
|
30233M503
|
||
(CUSIP Number)
|
August 11, 2021
|
||
(Date of Event which Requires Filing of this Statement)
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Lind Global Fund II LP
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) [ ]
|
|
(b) [x]
|
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization.
Delaware
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
1,302,933
|
6 Shared Voting Power
0
|
|
7 Sole Dispositive Power
1,302,933
|
|
8 Shared Dispositive Power
0
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,302,933(1)
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
9.9%
|
|
12
|
Type of Reporting Person (See Instructions)
PN
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Lind Global Partners II LLC
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) [ ]
|
|
(b) [x]
|
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization.
Delaware
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
1,302,933
|
6 Shared Voting Power
0
|
|
7 Sole Dispositive Power
1,302,933
|
|
8 Shared Dispositive Power
0
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,302,933(1)
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
9.9%
|
|
12
|
Type of Reporting Person (See Instructions)
OO
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Jeff Easton
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
(a) [ ]
|
|
(b) [x]
|
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization.
United States
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
1,302,933
|
6 Shared Voting Power
0
|
|
7 Sole Dispositive Power
1,302,933
|
|
8 Shared Dispositive Power
0
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,302,933(1)
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
9.9%
|
|
12
|
Type of Reporting Person (See Instructions)
IN
|
(a)
|
Name of Issuer
|
EyeGate Pharmaceuticals, Inc.
|
|
(b)
|
Address of Issuer’s Principal Executive Offices
|
271 Waverley Oaks Road, Suite 108
Waltham, MA 02452
|
(a)
|
Name of Person Filing
|
This statement is filed by the following entities and individuals (collectively, referred to as the “Reporting Persons”):
• Lind Global Fund II LP, a Delaware limited partnership;
• Lind Global Partners II LLC, a Delaware limited liability company; and
• Jeff Easton, an individual and a citizen of the United States of America.
Lind Global Partners II LLC, the general partner of Lind Global Fund II LP, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund II, LP.
Jeff Easton, the managing member of Lind Global Partners II LLC, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Fund II LP.
|
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
The address of the principal business office for each of the Reporting Persons is:
444 Madison Ave, Floor 41
New York, NY 10022
|
|
(c)
|
Citizenship
|
See Row 4 of cover page for each Reporting Person.
|
|
(d)
|
Title of Class of Securities
|
Common stock, $0.01 par value per share.
|
|
(e)
|
CUSIP Number
|
30233M503
|
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
Item 4. |
Ownership
|
(a)
|
Amount Beneficially Owned
|
See Row 9 of cover page for each Reporting Person.
|
|
(b)
|
Percent of Class
|
See Row 11 of cover page for each Reporting Person.
|
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
sole power to vote or to direct the vote
|
|
See Row 5 of cover page for each Reporting Person. |
||
(ii)
|
shared power to vote or to direct the vote
|
|
See Row 6 of cover page for each Reporting Person.
|
||
(iii)
|
sole power to dispose or to direct the disposition of
|
|
See Row 7 of cover page for each Reporting Person. |
||
(iv)
|
shared power to dispose or to direct the disposition of
|
|
See Row 8 of cover page for each Reporting Person.
|
Item 5. |
Ownership of Five Percent or Less of a Class
|
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person
|
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
|
Item 8. |
Identification and Classification of Members of the Group
|
Item 9. |
Notice of Dissolution of Group
|
Item 10. |
Certification
|
LIND GLOBAL FUND II LP
|
||
By:
|
|
Lind Global Partners II LLC
|
|
its General Partner
|
|
By:
|
/s/ Jeff Easton
|
|
Name:
|
|
Jeff Easton
|
Title:
|
|
Managing Member
|
LIND GLOBAL PARTNERS II LLC
|
||
By:
|
|
/s/ Jeff Easton
|
Name:
|
|
Jeff Easton
|
Title:
|
|
Managing Member
|
JEFF EASTON
|
||
By:
|
|
/s/ Jeff Easton
|
Name:
|
|
Jeff Easton
|